A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells
Senescent cells can influence the tumour microenvironment by secreting immunomodulatory factors and are thus a therapeutic target. Here, the authors identify a compound that degrades BET leading to DNA damage and activation of autophagy and a reduction in tumour growth.
Main Authors: | Masahiro Wakita, Akiko Takahashi, Osamu Sano, Tze Mun Loo, Yoshinori Imai, Megumi Narukawa, Hidehisa Iwata, Tatsuyuki Matsudaira, Shimpei Kawamoto, Naoko Ohtani, Tamotsu Yoshimori, Eiji Hara |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-15719-6 |
Similar Items
-
The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis?
by: Naoko Ohtani
Published: (2022-04-01) -
Local senolysis in aged mice only partially replicates the benefits of systemic senolysis
by: Joshua N. Farr, et al.
Published: (2023-04-01) -
Senolysis induced by 25-hydroxycholesterol targets CRYAB in multiple cell types
by: Chandani Limbad, et al.
Published: (2022-02-01) -
Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice
by: Araceli Lérida-Viso, et al.
Published: (2022-09-01) -
Targeting Multiple Homeostasis-Maintaining Systems by Ionophore Nigericin Is a Novel Approach for Senolysis
by: Pavel I. Deryabin, et al.
Published: (2022-11-01)